IP Update: Recent Patents, Patent Applications Awarded to Thermo Fisher Scientific, Marina, Alnylam, and More | GenomeWeb

Title: Vector

Patent Number: 8,501,466

Filed: Dec. 17, 2009

Lead Inventor: Venugopal Nair, Pirbright Institute

The invention, the patent’s abstract states, relates to a “herpes virus vector [comprising] a modified genomic sequence encoding a microRNA against a target sequence. The herpes virus vector may be used as or in a vaccine to prevent and/or treat a disease.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.